Development of a sensitive and quantitative PD-L1 immunoassay superior to IHC with application in human FFPE tissue samples

被引：0
|
作者：
Wallweber, Gerald [1 ]
Chenna, Ahmed [1 ]
Ravanera, Roy [1 ]
Stathas, David [1 ]
Huang, Weidong [1 ]
Petropoulos, Christos [1 ]
机构：
[1] Monogram Biosci, San Francisco, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-LB-281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-281
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples
    An, E.
    Liao, W.
    Thyparambil, S.
    Rodriguez, J.
    Salgia, R.
    Wistuba, I.
    Burrows, J.
    Hembrough, T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 159 - 159
  • [2] Development of IHC staining protocols for assessment of PD-L1 expression in cytological samples
    Boyiddle, Christine
    Ruboyianes, Mark
    Del Valle, Ed
    Bubendorf, Lukas
    Trunzer, Kerstin
    Pugh, Judith
    Boone, Jennifer
    CANCER RESEARCH, 2017, 77
  • [3] Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples.
    An, Eunkyung
    Liao, Wei-Li
    Thyparambil, Sheeno
    Rodriguez, Jaime
    Salgia, Ravi
    Wistuba, Ignacio I.
    Burrows, Jon
    Hembrough, Todd
    CLINICAL CANCER RESEARCH, 2014, 20
  • [4] PD-L1 antigen stability using PD-L1 IHC pharmDx on human cancer tissues
    Kalpakoff, Megan
    Olander, Emily
    Jones, Kelci
    Hund, Stephanie
    Evans, Tiffany
    Barreto, Joseph
    Moquin, Deanna
    Toland, Grant
    Tabuena-Frolli, Siena
    Kersch, Kristopher
    Kulangara, Karina
    Musser, Jeanette
    CANCER RESEARCH, 2024, 84 (06)
  • [5] PD-L1 Expression in IPF Tissue Samples
    Jovanovic, D.
    Markovic, J.
    Glumac, S.
    Skodric-Radojevic, S.
    Skodric-Trifunovic, V.
    Roksandic-Milenkovic, M.
    Vukanic, I.
    Popevic, S.
    Samardzic, N.
    Kontic, M.
    Ceriman, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Development of a proximity-based immunoassay to measure the PD1:PD-L1 complex in fixed samples
    Wallweber, Gerald
    Ravanera, Roy
    Chenna, Ahmed
    Stathas, David
    Huang, Weidong
    Winslow, John
    Petropoulos, Christos
    CANCER RESEARCH, 2016, 76
  • [7] Validation of VENTANA (SP263) PD-L1 immunohistochemistry (IHC) assay in formalin-fixed, paraffin embedded (FFPE) cytology samples
    Barker, C.
    Horne, H.
    Scorer, P.
    Roland, B.
    Hayden, D.
    Schnittker, K.
    VIRCHOWS ARCHIV, 2021, 479 : S158 - S159
  • [8] Efficiency of Cytology Samples for PD-L1 Evaluation and Comparison with Tissue Samples
    Kulac, Ibrahim
    Aydin, Asli
    Bulutay, Pinar
    Firat, Pinar
    TURKISH JOURNAL OF PATHOLOGY, 2020, 36 (03) : 205 - 210
  • [9] PD-L1 (SP263) staining of fine needle aspirate FFPE samples in NSCLC
    Hayden, D.
    Roland, B.
    Saufkie, K.
    Largo, S.
    Ahmadi, P.
    Vasquez, M.
    Newell, A. E. Hanlon
    Schnittker, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1113 - S1113
  • [10] Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934
    Sompuram, Seshi R.
    Torlakovic, Emina E.
    't Hart, Nils A.
    Vani, Kodela
    Bogen, Steven A.
    MODERN PATHOLOGY, 2022, 35 (03) : 326 - 332
12345